Concepedia

Jonathan Almaden

JA

Statistics

Publications

8

Citations

453

H-Index

8

Active since

2005

Affiliations

Pfizer (United States)(Current)

University of California, Los Angeles

University of California San Diego

Center for Systems Biology

Jonathan Almaden is an author at Pfizer (United States) specializing in life sciences, cell signaling, and nuclear factor kappa b signaling.

Publications per year

2005–2024

8

Publications

8

Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor

Kevin D. Freeman‐Cook, Robert L. Hoffman, Nichol Miller et al. · Cancer Cell · 2021 · 186 citations

, , +14

IκBε Is a Key Regulator of B Cell Expansion by Providing Negative Feedback on cRel and RelA in a Stimulus-Specific Manner

Bryce N. Alves, Rachel Tsui, Jonathan Almaden et al. · The Journal of Immunology · 2014 · 64 citations · Full text

, , +16

A Pathway Switch Directs BAFF Signaling to Distinct NFκB Transcription Factors in Maturing and Proliferating B Cells

Jonathan Almaden, Rachel Tsui, Yi Liu et al. · Cell Reports · 2014 · 52 citations · Full text

, , +15

B-cell survival and development controlled by the coordination of NF-κB family members RelB and cRel

Jonathan Almaden, Edward Yang, Dennis C. Otero et al. · Blood · 2016 · 50 citations · Full text

, , +13

A multi‐scale approach reveals that NF‐κB cRel enforces a B‐cell decision to divide

Maxim N. Shokhirev, Jonathan Almaden, Jeremy Davis‐Turak et al. · Molecular Systems Biology · 2015 · 35 citations · Full text

, , +15

1–5 of 8